KATHLEEN MARABLE BURKE: Open Payments
NPI 1033873880 · GROVE CITY, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$615 in 32 payments from 15 companies in 2025. Trend: 2023 $327 · 2024 $438 · 2025 $615
Food & beverage: $615
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $82 |
| ABBVIE INC. | 4 | $79 |
| Dexcom, Inc. | 2 | $51 |
| Exact Sciences Corporation | 2 | $51 |
| Novo Nordisk Inc | 3 | $50 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $49 |
| Otsuka America Pharmaceutical, Inc. | 2 | $40 |
| PFIZER INC. | 2 | $39 |
| Lilly USA, LLC | 2 | $35 |
| GlaxoSmithKline, LLC. | 2 | $34 |
Products named: VRAYLAR, Dexcom G6 Transmitter, Cologuard Collection Kit, CAPLYTA, REXULTI, ELIQUIS, TRELEGY ELLIPTA, BREZTRI.
Industry payments across OH — which companies pay providers there.
